Cargando…

Expression of G3BP1 in benign and malignant human prostate tissues

BACKGROUND: Prostate cancer (PCa) is the world’s leading type of cancer in men. GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) is overexpressed in a variety of tumors. However, there are limited studies in PCa concerning G3BP1. This present study was to investigates the expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chao, Cui, Qiqi, Du, Runxuan, Liu, Shuang, Tian, Shaoping, Huang, Hua, Jiang, Yihua, Chen, Ruibing, Niu, Yuanjie, Yue, Dan, Wang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100838/ https://www.ncbi.nlm.nih.gov/pubmed/33968655 http://dx.doi.org/10.21037/tau-20-1450

Ejemplares similares

The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis
por: Wang, Yong, et al.
Publicado: (2019)

C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation
por: Wang, Yiting, et al.
Publicado: (2022)

G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas
por: Wang, Yong, et al.
Publicado: (2018)

G3BP1 regulates breast cancer cell proliferation and metastasis by modulating PKCζ
por: Liu, Shuang, et al.
Publicado: (2022)

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis
por: Yang, Yang, et al.
Publicado: (2022)

Research Progress on the Structure and Function of G3BP
por: Kang, Weifang, et al.
Publicado: (2021)

Benign or Malignant? Two Case Reports of Gigantic Prostatic Cyst
por: Yu, Jiang, et al.
Publicado: (2016)

Ebp1 expression in benign and malignant prostate
por: Gannon, Philippe O, et al.
Publicado: (2008)

Factors that influence the androgen receptor cistrome in benign and malignant prostate cells
por: Copeland, Ben T., et al.
Publicado: (2019)

Prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate Prostate Cancer from Benign Prostate Hyperplasia
por: Fu, Shuang, et al.
Publicado: (2018)

G3BP1 modulates SPOP to promote prostate tumorigenesis
por: Mukhopadhyay, Chandrani, et al.
Publicado: (2022)

Endometriosis: benign, malignant, or something in between?
por: Chui, M. Herman, et al.
Publicado: (2017)

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
por: Rådestad, Emelie, et al.
Publicado: (2017)

Prostate imaging features that indicate benign or malignant pathology on biopsy
por: Lovegrove, Catherine Elizabeth, et al.
Publicado: (2018)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
por: Xing, Nianzeng, et al.
Publicado: (2012)

The expression and significance of p4E‐BP1/4E‐BP1 in prostate cancer
por: Wang, Kai‐yun, et al.
Publicado: (2022)

An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease.
por: McClinton, S., et al.
Publicado: (1990)

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
por: Howarth, D. J., et al.
Publicado: (1997)

Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate
por: Dueregger, Andrea, et al.
Publicado: (2015)

Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms
por: Anunobi, Charles C., et al.
Publicado: (2016)

Comparative Expression of RAGE and SOX2 in Benign and Malignant Prostatic Lesions
por: Aboushousha, Tarek, et al.
Publicado: (2019)

Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules
por: Kuang, Muyu, et al.
Publicado: (2019)

Sex Steroid Metabolism in Benign and Malignant Intact Prostate Biopsies: Individual Profiling of Prostate Intracrinology
por: Gianfrilli, Daniele, et al.
Publicado: (2014)

Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies
por: Sharif, Mohammad Reza, et al.
Publicado: (2014)

AB067. Transurethral endoscopic treatment of benign prostatic hyperplasia
por: Meng, Qingjun, et al.
Publicado: (2017)

Exophytic benign prostatic hyperplasia presenting as a polycystic pelvic mass
por: Xu, Shuang, et al.
Publicado: (2023)

Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women
por: Romppanen, J, et al.
Publicado: (1999)

Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue
por: Bründl, Johannes, et al.
Publicado: (2018)

G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer
por: Mukhopadhyay, Chandrani, et al.
Publicado: (2021)

Small RNAs as biomarkers to differentiate benign and malign prostate diseases: An alternative for transrectal punch biopsy of the prostate?
por: Markert, Lukas, et al.
Publicado: (2021)

DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml
por: Sun, Hongmei, et al.
Publicado: (2022)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
por: Xiang, Peng, et al.
Publicado: (2020)

Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study
por: Yang, Lu, et al.
Publicado: (2023)

Adult metanephric adenoma presumed to be all benign? A clinical perspective
por: Li, Gang, et al.
Publicado: (2015)

Benign Prostatic Hyperplasia
Publicado: (2015)

AB091. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells
por: Wang, Yong, et al.
Publicado: (2017)

AB094. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis
por: Wang, Yong, et al.
Publicado: (2017)

AB093. C1QBP regulates YBX1 to suppress the androgen receptor (AR)-enhanced RCC cell invasion
por: Wang, Yong, et al.
Publicado: (2017)

Acoustic Radiation Force Impulse Imaging for the Differentiation of Benign and Malignant Lymph Nodes: A Systematic Review and Meta-Analysis
por: Zhang, Peige, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t5i011438l75upngnkn4kjnvdm